Skip to main content

Compare available tests

Acute Lymphoblastic Leukemia (ALL) Testing

ALL Cytogenetic & ETV6-RUNX1 Panels

Catalog role labels reflect current assignments. Test choice, timing and prices require clinician or laboratory confirmation.

  • KMLTTB Regulated Laboratory
  • ISO 9001:2015 Quality System
  • Free Pre-Test Counselor Guidance
  • Nationwide & Home Sample Collection

Test comparison

5 tests

All diagnostic topics
First-line screen

Acute Lymphoblastic Leukemia All Cytogenetics Panel Test

Sample type
8 mL (6 mL min.) whole blood from 2 Green Top (Sodium Heparin) tubes AND 4 mL (2 mL min.) Bone Marrow from 1 Green Top (Sodium Heparin) tube.
Turnaround
Timing on request
Price
KSh 40,000
First-line screen

T1221 P13Q22 ETV6RUNX1 TELAML1 PCR Qualitative Test

Sample type
3 mL of whole blood or bone marrow collected in a Lavender Top (EDTA) tube.
Turnaround
See timing details Sample received by Monday or Thursday before 11 am; report available Wednesday or Saturday.
Price
KSh 10,000
First-line screen

ETV6 Gene Thrombocytopenia Type 5 Genetic Test

Sample type
A blood sample (usually collected in an EDTA tube) or extracted DNA.
Turnaround
Timing on request
Price
KSh 40,000
First-line screen

PAX5 Gene Leukemia Acute Lymphoblastic Susceptibility Due to PAX5 Germline Mutation Genetic Test

Sample type
Blood sample (EDTA tube), extracted DNA, or one drop of blood on an FTA card.
Turnaround
4 Weeks Typically 3 to 4 weeks.
Price
KSh 40,000
First-line screen

EZH2 Gene Leukemia Lymphoblastic and Myeloid EZH2 Related Genetic Test

Sample type
Blood sample (EDTA tube) or Bone Marrow sample. Confirm specific requirements with the laboratory before booking.
Turnaround
Timing on request
Price
KSh 40,000

Clinical context

Clinical testing guide & how to choose

Tests in Acute Lymphoblastic Leukemia (ALL) Testing answer different clinical questions. This catalogue supports a conversation with your clinician or counselor; it does not establish a diagnosis or replace an individual assessment.

Choosing a test

A comprehensive panel measures several related markers, while a single-marker test addresses a more focused question. A larger panel is not automatically the right choice. Discuss your symptoms, previous results and referral with a qualified clinician before selecting tests. Results should not be interpreted in isolation.

Before sample collection

Confirm the required tube, sample volume, any fasting instructions and the collection deadline for your chosen test. Tell the collection team about medication and recent treatment. Do not stop prescribed medication unless your clinician advises it. Home collection depends on the sample’s handling and transport requirements.

Common questions

Questions before booking

Should I choose a panel or a single-marker test for Acute Lymphoblastic Leukemia (ALL) Testing?

A comprehensive panel measures several related markers, while a single-marker test addresses a more focused question. A larger panel is not automatically the right choice. Discuss your symptoms, previous results and referral with a qualified clinician before selecting tests. Results should not be interpreted in isolation. Free pre-test counselor guidance is available to help you understand the booking options.

Can I use SHIF/SHA or private insurance for these tests?

Coverage depends on your scheme, the specific test, referral and authorization requirements, and the provider arrangement. Before booking, ask the laboratory and your insurer to verify eligibility, any co-payment, and whether direct billing or reimbursement applies. Listing a test here does not guarantee insurance coverage.

When should I arrange sample collection?

Check the sample and preparation notes for the specific test, then confirm the collection time and reporting deadline with the laboratory. Same-day reporting, where listed, may depend on a collection cutoff and working days. Nationwide and home sample collection are available subject to location, sample suitability and transport arrangements.

Quick factsheet

Sample
Preparation
Turnaround